<?xml version="1.0" encoding="UTF-8"?><!-- generator="wordpress/2.2.1" -->
<rss version="2.0" 
	xmlns:content="http://purl.org/rss/1.0/modules/content/">
<channel>
	<title>Comments on: Another Trade</title>
	<link>http://stockmarketbeat.com/blog1/2006/08/02/another-trade/</link>
	<description>Our beat: The stock market. Our job: Beat it.</description>
	<pubDate>Tue, 06 Jan 2009 01:39:59 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.2.1</generator>

	<item>
		<title>By: Ceradyne&#8217;s (CRDN) Good News is No News - Stock Market Beat - Our beat is the stock market. Our job is to beat it.</title>
		<link>http://stockmarketbeat.com/blog1/2006/08/02/another-trade/#comment-10480</link>
		<author>Ceradyne&#8217;s (CRDN) Good News is No News - Stock Market Beat - Our beat is the stock market. Our job is to beat it.</author>
		<pubDate>Thu, 11 Jan 2007 15:12:02 +0000</pubDate>
		<guid>http://stockmarketbeat.com/blog1/2006/08/02/another-trade/#comment-10480</guid>
		<description>[...] We have done about as well this year betting that Ceradyne (CRDN) would not go down as we could have betting it would go up (click on the link for the distinction.) The company has significantly raised guidance (twice) so coming in at the high end should have been somewhat expected:   For the year, sales reached $663 million, 80 percent above the $368 million reported in 2005, and total new orders hit about $730 million, up 64 percent year-over-year. Due to the strong demand for its services, Ceradyne predicts full-year earnings will come in at the high end of its $4.45 to $4.55 per share range. [...]</description>
		<content:encoded><![CDATA[<p>[&#8230;] We have done about as well this year betting that Ceradyne (CRDN) would not go down as we could have betting it would go up (click on the link for the distinction.) The company has significantly raised guidance (twice) so coming in at the high end should have been somewhat expected:   For the year, sales reached $663 million, 80 percent above the $368 million reported in 2005, and total new orders hit about $730 million, up 64 percent year-over-year. Due to the strong demand for its services, Ceradyne predicts full-year earnings will come in at the high end of its $4.45 to $4.55 per share range. [&#8230;]</p>
]]></content:encoded>
	</item>
</channel>
</rss>
